Publication | Closed Access

Incidence of bleeding complications associated with abciximab use in conjunction with thrombolytic therapy in patients requiring percutaneous transluminal coronary angioplasty

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseThrombolytic TherapyAtherosclerosisCoronary Artery DiseaseVascular SurgeryAnticoagulantAcute Myocardial InfarctionMedicineAbciximab UseCardiologyEmergency MedicineAnesthesiology